The MCL Consortium consists of independent,Â multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers.
If you'd like to join us, sibrede.
COMING UP SOON:
MCL 7th Semiannual Steering Committee Meeting
The MCL Consortium will hold its 7th Face-to-Face Steering Committee Meeting in Nashville, TN - April 24 - 27, 2019. More information coming soon.